Free Trial
→ BSEM: From OTC to Nasdaq Contender! (From Huge Alerts) (Ad)tc pixel Free LSTA Stock Alerts

Lisata Therapeutics (LSTA) Institutional Ownership

Lisata Therapeutics logo
$3.31 +0.05 (+1.53%)
As of 02:58 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Lisata Therapeutics (NASDAQ:LSTA)

Current
Institutional Ownership
Percentage
8.94%
Number of
Institutional Buyers
(last 12 months)
6
Total
Institutional Inflows
(last 12 months)
$687.64K
Number of
Institutional Sellers
(last 12 months)
2
Total
Institutional Outflows
(last 12 months)
$375.37K
Get LSTA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Lisata Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

LSTA Institutional Buying and Selling by Quarter

Lisata Therapeutics Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
4/25/2026 SOL Capital Management CO12,175$61K0.0%N/A0.135%
4/24/2026 Deltec Asset Management LLC90,000$451K0.1%N/A0.997%
2/12/2026Renaissance Technologies LLC123,715$230K0.0%+6.1%1.403%
2/12/2026 Dimensional Fund Advisors LP14,253$27K0.0%-32.0%0.162%
2/4/2026 Ground Swell Capital LLC38,987$73K0.2%+64.0%0.442%
2/3/2026 BML Capital Management LLC73,348$136K0.1%-33.2%0.832%
11/21/2025CIBC Bancorp USA Inc.13,982$37K0.0%N/A0.159%
11/12/2025 Dimensional Fund Advisors LP20,947$55K0.0%-18.8%0.239%
11/10/2025 BML Capital Management LLC109,841$288K0.2%-47.6%1.254%
11/6/2025 Ground Swell Capital LLC23,774$62K0.1%N/A0.272%
8/14/2025Cerity Partners LLC12,183$32K0.0%N/A0.139%
8/11/2025 BML Capital Management LLC209,814$608K0.5%-3.2%2.395%
5/7/2025BML Capital Management LLC216,853$510K0.4%-23.8%2.517%
2/17/2025Citadel Advisors LLC23,273$69K0.0%N/A0.277%
2/14/2025Dimensional Fund Advisors LP25,226$75K0.0%+45.5%0.301%
8/9/2024Dimensional Fund Advisors LP17,336$60K0.0%+48.2%0.209%
4/23/2024BML Capital Management LLC284,669$888K0.6%+5.5%3.426%
1/30/2024BML Capital Management LLC269,839$737K0.6%+10.7%3.315%
2/13/2023BML Capital Management LLC243,839$617K0.6%N/A3.102%


LSTA Institutional Ownership - Frequently Asked Questions

During the previous two years, 9 institutional investors and hedge funds held shares of Lisata Therapeutics. The most heavily invested institutionals were Deltec Asset Management LLC ($451K), Renaissance Technologies LLC ($230K), BML Capital Management LLC ($136K), Ground Swell Capital LLC ($73K), Citadel Advisors LLC ($69K), SOL Capital Management CO ($61K), and CIBC Bancorp USA Inc. ($37K).Learn more on Lisata Therapeutics' institutional investors.

8.94% of Lisata Therapeutics' stock is owned by institutional investors. Learn more on LSTA's institutional investor holdings.

The following institutional investors have purchased Lisata Therapeutics' stock in the last 24 months: Deltec Asset Management LLC ($90K), Ground Swell Capital LLC ($38.99K), Citadel Advisors LLC ($23.27K), CIBC Bancorp USA Inc. ($13.98K), Dimensional Fund Advisors LP ($13.53K), Cerity Partners LLC ($12.18K), and SOL Capital Management CO ($12.18K).

Institutional investors have bought a total of 174,420 shares in the last 24 months. This purchase volume represents approximately $687.64K in transactions.

The following institutional investors have sold Lisata Therapeutics stock in the last 24 months: BML Capital Management LLC ($143.51K), and Dimensional Fund Advisors LP ($11.54K).

Institutional investors have sold a total of 155,045 shares in the last 24 months. This volume of shares sold represents approximately $375.37K in transactions.


Related Companies

This page (NASDAQ:LSTA) was last updated on 5/12/2026 by MarketBeat.com Staff.
From Our Partners
NNVC FDA = New Momentum Wave!
NanoViricides (NYSE: NNVC) just received FDA Orphan Drug Designation for NV-387, its antiviral candidate targe...
Equiscreen | Sponsoredtc pixel
BSEM: From OTC to Nasdaq Contender!
BioStem Technologies (OTC: BSEM) has posted seven consecutive profitable quarters and just released audited fi...
Huge Alerts | Sponsoredtc pixel
If You Have $50k+ on Coinbase, This Will Ruin Your Day
In 2009, Greece's debt-to-GDP ratio hit 130%. Within 24 months... Pensions were slashed 40% overnight. Bank ac...
Decentralized Masters | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Rise of the… petroyuan?
On February 28th, Iran installed a yuan-denominated toll at the Strait of Hormuz - the chokepoint for one in e...
Golden Portfolio | Sponsoredtc pixel
Nevada gold explorer near Kinross district draws attention
Gold has surged past $5,300 per ounce, with Goldman Sachs and JPMorgan forecasting $6,000+ by end of 2026. Cen...
Wall Street Logic | Sponsoredtc pixel
Read this or regret it forever
Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...
Porter & Company | Sponsoredtc pixel